← Back to Search

Aerobic exercise for Cancer

N/A
Recruiting
Led By Ryan Marker
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary cancer diagnosis of breast, prostate, or colorectal cancer
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights

Study Summary

This trial aims to study the effects of excess body fat on fitness, hormone levels, and metabolic responses in cancer survivors. The study will include overweight, obese, and normal weight survivors of breast, prostate

Who is the study for?
This trial is for breast, prostate, or colorectal cancer survivors who are overweight or obese. They should have finished their cancer treatments between 6 months and 5 years ago and must be able to do supervised exercise with a doctor's clearance.Check my eligibility
What is being tested?
The study tests how body fat affects fitness levels and the body's response to a standardized 15-week aerobic exercise program in terms of cardiorespiratory fitness (CRF) and insulin-like growth factor-1 (IGF-1).See study design
What are the potential side effects?
While not drug-related, potential side effects from the aerobic exercise may include muscle soreness, fatigue, joint pain, or injury due to increased physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My cancer is either breast, prostate, or colorectal.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention Adherence
Recruitment
Study Adherence
Secondary outcome measures
Estimated VO2max
Serum IGF-1
Total visceral adiposity

Trial Design

1Treatment groups
Experimental Treatment
Group I: Aerobic exerciseExperimental Treatment1 Intervention
15-week standardized aerobic exercise intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Aerobic Exercise
2013
Completed Early Phase 1
~1310

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,738 Previous Clinical Trials
2,149,506 Total Patients Enrolled
Ryan MarkerPrincipal InvestigatorUniversity of Colorado, Denver

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for this research study still ongoing?

"Indeed, the information provided on clinicaltrials.gov indicates that this particular clinical trial is currently seeking eligible participants. The trial was initially posted on December 1st, 2024 and subsequently updated on January 12th, 2024. The study aims to enroll a total of 20 patients from a single location."

Answered by AI

What is the total number of people involved in this clinical trial?

"Indeed, the information available on clinicaltrials.gov indicates that this study is actively seeking eligible participants. The trial was originally posted on December 1st, 2024 and last updated on January 12th, 2024. A total of 20 patients are being sought at a single designated site."

Answered by AI

Are individuals aged 18 and above eligible to participate in this clinical trial?

"To be eligible for this research study, patients must fall within the age range of 21 to 79 years old. Out of the total number of clinical trials listed, there are 107 trials available specifically for patients under the age of 18 and 676 trials targeting individuals over the age of 65."

Answered by AI

Which individuals meet the eligibility criteria for participation in this research endeavor?

"This clinical trial aims to enroll 20 participants, aged between 21 and 79, who have been diagnosed with cancer. In addition to meeting the age and diagnosis criteria, patients must fulfill the following requirements: they should have completed all cancer-related treatments more than six months but less than five years prior to joining the study, be capable of and willing to participate in a supervised exercise program, and obtain physician clearance by signing an exercise participation form before enrollment."

Answered by AI
~13 spots leftby Sep 2025